Two Sigma Investments’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $659K | Buy |
+11,700
| New | +$762K | ﹤0.01% | 3540 |
|
|
2025
Q3 | – | Sell |
-7,122
| Closed | -$531K | – | 3761 |
|
|
2025
Q2 | $531K | Buy |
+7,122
| New | +$472K | ﹤0.01% | 2561 |
|
|
2025
Q1 | – | Sell |
-58,799
| Closed | -$4.59M | – | 3309 |
|
|
2024
Q4 | $4.59M | Sell |
58,799
-18,675
| -24% | -$1.5M | 0.01% | 1157 |
|
|
2024
Q3 | $6.23M | Sell |
77,474
-32,230
| -29% | -$2.6M | 0.01% | 967 |
|
|
2024
Q2 | $9.08M | Buy |
+109,704
| New | +$9.65M | 0.02% | 748 |
|
|
2023
Q4 | – | Sell |
-16,687
| Closed | -$1.49M | – | 3236 |
|
|
2023
Q3 | $1.49M | Sell |
16,687
-37,896
| -69% | -$3.38M | ﹤0.01% | 1662 |
|
|
2023
Q2 | $4.65M | Buy |
54,583
+26,418
| +94% | +$2.23M | 0.01% | 953 |
|
|
2023
Q1 | $2.33M | Sell |
28,165
-81,935
| -74% | -$6.63M | 0.01% | 1288 |
|
|
2022
Q4 | $8.66M | Buy |
110,100
+34,771
| +46% | +$2.79M | 0.03% | 620 |
|
|
2022
Q3 | $5.58M | Sell |
75,329
-186,125
| -71% | -$13.4M | 0.02% | 717 |
|
|
2022
Q2 | $17M | Sell |
261,454
-189,225
| -42% | -$11.2M | 0.06% | 364 |
|
|
2022
Q1 | $28.5M | Buy |
450,679
+25,784
| +6% | +$1.4M | 0.08% | 301 |
|
|
2021
Q4 | $22.5M | Sell |
424,895
-64,389
| -13% | -$3.92M | 0.05% | 438 |
|
|
2021
Q3 | $34.5M | Buy |
489,284
+223,568
| +84% | +$14.1M | 0.08% | 283 |
|
|
2021
Q2 | $17.7M | Buy |
265,716
+142,425
| +116% | +$10.1M | 0.04% | 536 |
|
|
2021
Q1 | $13.7M | Buy |
123,291
+94,461
| +328% | +$11.7M | 0.04% | 575 |
|
|
2020
Q4 | $3.42M | Sell |
28,830
-239,816
| -89% | -$25.8M | 0.01% | 1149 |
|
|
2020
Q3 | $23.4M | Buy |
268,646
+48,394
| +22% | +$4.23M | 0.08% | 260 |
|
|
2020
Q2 | $19.7M | Buy |
220,252
+171,452
| +351% | +$17.3M | 0.1% | 214 |
|
|
2020
Q1 | $4.86M | Sell |
48,800
-182,362
| -79% | -$19.8M | 0.04% | 522 |
|
|
2019
Q4 | $26.6M | Buy |
231,162
+166,903
| +260% | +$20.2M | 0.08% | 291 |
|
|
2019
Q3 | $8.11M | Buy |
64,259
+46,866
| +269% | +$5.95M | 0.03% | 636 |
|
|
2019
Q2 | $2.09M | Sell |
17,393
-82,907
| -83% | -$8.16M | 0.01% | 1415 |
|
|
2019
Q1 | $8.77M | Buy |
100,300
+54,475
| +119% | +$4.95M | 0.03% | 708 |
|
|
2018
Q4 | $4.58M | Buy |
+45,825
| New | +$4.81M | 0.02% | 840 |
|
|
2018
Q3 | – | Sell |
-100,701
| Closed | -$9.03M | – | 3341 |
|
|
2018
Q2 | $9.03M | Buy |
100,701
+92,159
| +1,079% | +$7.78M | 0.03% | 713 |
|
|
2018
Q1 | $625K | Sell |
8,542
-235,481
| -96% | -$16.2M | ﹤0.01% | 2338 |
|
|
2017
Q4 | $14.2M | Buy |
244,023
+231,579
| +1,861% | +$12.2M | 0.05% | 468 |
|
|
2017
Q3 | $558K | Buy |
+12,444
| New | +$517K | ﹤0.01% | 2078 |
|
|
2016
Q4 | – | Sell |
-7,488
| Closed | -$271K | – | 3273 |
|
|
2016
Q3 | $271K | Buy |
+7,488
| New | +$257K | ﹤0.01% | 2808 |
|
|
2016
Q2 | – | Sell |
-58,730
| Closed | -$2.05M | – | 3019 |
|
|
2016
Q1 | $2.05M | Buy |
+58,730
| New | +$1.9M | 0.01% | 1170 |
|
|
2014
Q4 | – | Sell |
-8,600
| Closed | -$300K | – | 2278 |
|
|
2014
Q3 | $300K | Sell |
8,600
-122,407
| -93% | -$4.37M | ﹤0.01% | 1477 |
|
|
2014
Q2 | $4.62M | Sell |
131,007
-88,181
| -40% | -$2.95M | 0.02% | 730 |
|
|
2014
Q1 | $7.14M | Buy |
219,188
+209,015
| +2,055% | +$7.99M | 0.04% | 520 |
|
|
2013
Q4 | $429K | Buy |
+10,173
| New | +$419K | ﹤0.01% | 1729 |
|
Other funds holding HAE
VPM
VCM
RRAM
Two Sigma Investments's HAE Position: Q1 2026 in Review
Two Sigma Investments opened a new position in Haemonetics (HAE) in Q1 2026: 11,700 shares worth $659K. The stake represents ﹤0.01% of the portfolio and ranks #3540 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in HAE as recently as Q2 2025.
Two Sigma Investments first reported a position in HAE in Q4 2013 and has held it in 35 quarters since. The position peaked at $34.5M in Q3 2021. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Two Sigma Investments held 11,700 shares of Haemonetics worth $659K as of Q1 2026.
- Haemonetics was a new Two Sigma Investments position in Q1 2026.
- Haemonetics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3540 holding.
- Two Sigma Investments first reported a position in Haemonetics in Q4 2013 and has held it in 35 quarters since.
- Two Sigma Investments's Haemonetics position peaked at $34.5M in Q3 2021.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.